<DOC>
	<DOC>NCT00171782</DOC>
	<brief_summary>A study to evaluate the efficacy of valsartan+chydochlorothiazide in patients with stage 2 hypertension and cardiovascular risk factors.</brief_summary>
	<brief_title>Hypertension and Cardiovascular Risk Factors</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Patients who give consent Men and women 18 to 80 years of age Patients with hypertension (systolic &gt;159 mm, diastolic &gt;100 mm) Patients meeting laboratory criteria Pregnant women Women not using approved contraception methods Secondary hypertension Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>HYPERTENSION</keyword>
	<keyword>VALSARTAN</keyword>
	<keyword>VALSARTAN AND HYDROCHLOROTHIAZIDE</keyword>
	<keyword>RISK FACTORS</keyword>
</DOC>